{
    "title": "Febuxostat induced Stevens Johnson syndrome: A case report.",
    "doc_id": "39973416",
    "writer": "Sidhu JK",
    "year": "2024",
    "summary": "Background: Febuxostat is a novel non-purine selective xanthine oxidase inhibitor with superior ability to lower serum urate levels than allopurinol.Case Report: We report a case of Stevens Johnson syndrome following febuxostat administration.Conclusion: This cas â€¦",
    "abstract": "Background: Febuxostat is a novel non-purine selective xanthine oxidase inhibitor with superior ability to lower serum urate levels than allopurinol.Case Report: We report a case of Stevens Johnson syndrome following febuxostat administration.Conclusion: This case report underlines the necessity of recognising this major mucocutaneous adverse reaction and the need for cautious medication usage.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/39973416/",
    "clean_text": "febuxostat induced stevens johnson syndrome a case report background febuxostat is a novel non purine selective xanthine oxidase inhibitor with superior ability to lower serum urate levels than allopurinol case report we report a case of stevens johnson syndrome following febuxostat administration conclusion this cas background febuxostat is a novel non purine selective xanthine oxidase inhibitor with superior ability to lower serum urate levels than allopurinol case report we report a case of stevens johnson syndrome following febuxostat administration conclusion this case report underlines the necessity of recognising this major mucocutaneous adverse reaction and the need for cautious medication usage"
}